Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

BUY
$29.35 - $34.19 $33,664 - $39,215
1,147 Added 12.44%
10,365 $322,000
Q1 2022

Apr 26, 2022

BUY
$32.56 - $40.56 $97,289 - $121,193
2,988 Added 47.96%
9,218 $312,000
Q4 2021

Jan 25, 2022

SELL
$36.93 - $42.14 $18,760 - $21,407
-508 Reduced 7.54%
6,230 $263,000
Q3 2021

Oct 25, 2021

SELL
$35.36 - $44.01 $51,165 - $63,682
-1,447 Reduced 17.68%
6,738 $276,000
Q2 2021

Jul 19, 2021

SELL
$29.45 - $35.85 $40,375 - $49,150
-1,371 Reduced 14.35%
8,185 $291,000
Q1 2021

Apr 30, 2021

BUY
$26.83 - $30.69 $70,884 - $81,082
2,642 Added 38.21%
9,556 $276,000
Q4 2020

Feb 05, 2021

SELL
$22.9 - $28.15 $880,115 - $1.08 Million
-38,433 Reduced 84.75%
6,914 $195,000
Q3 2020

Oct 28, 2020

BUY
$16.99 - $22.79 $770,445 - $1.03 Million
45,347 New
45,347 $1.02 Million

Others Institutions Holding AVTR

About Avantor, Inc.


  • Ticker AVTR
  • Exchange NYSE
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 674,035,008
  • Market Cap $14B
  • Description
  • Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulate...
More about AVTR
Track This Portfolio

Track Convergence Investment Partners, LLC Portfolio

Follow Convergence Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Convergence Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Convergence Investment Partners, LLC with notifications on news.